Orit Pinchuk
Fortuna: 99 161 $ al 31/08/2026
Fortuna: 99 161 $ al 31/08/2026
Orit Pinchuk is currently Vice President-Regulatory Affairs & PVG at Kamada Ltd. since 2014.
Formerly, Ms. Pinchuk was Senior Director-Research & Development at Teva Pharmaceutical Industries Ltd. from 2011 to 2014.
Education includes graduate studies at The Hebrew University of Jerusalem and undergraduate studies at Shenkar College of Engineering & Design.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KAMADA LTD 0,02 % | 07/04/2026 | 12.133 ( 0,02 % ) | 99 161 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KAMADA LTD. | Consejero General | 01/10/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/03/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Shenkar College of Engineering & Design
Shenkar College of Engineering & Design Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.